Teva Pharmaceuticals
TEVA
TEVA
737 hedge funds and large institutions have $21.8B invested in Teva Pharmaceuticals in 2016 Q4 according to their latest regulatory filings, with 119 funds opening new positions, 239 increasing their positions, 303 reducing their positions, and 164 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
23% less funds holding in top 10
Funds holding in top 10: 35 → 27 (-8)
27% less first-time investments, than exits
New positions opened: 119 | Existing positions closed: 164
33% less call options, than puts
Call options by funds: $433M | Put options by funds: $645M
Holders
737
Holding in Top 10
27
Calls
$433M
Puts
$645M
Top Buyers
| 1 | +$939M | |
| 2 | +$502M | |
| 3 | +$390M | |
| 4 |
HCM
Highfields Capital Management
Boston,
Massachusetts
|
+$347M |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$289M |
Top Sellers
| 1 | -$906M | |
| 2 | -$416M | |
| 3 | -$285M | |
| 4 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
-$265M |
| 5 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
-$186M |